Info

The Third Wave

The Third Wave Podcast explores the many minds of the emerging psychedelic renaissance. Through conversations with thought leaders across various disciplines, we explore how psychedelics, when used with intention and responsibility, catalyze transformation on both an individual and collective level. Are you a newbie fresh off an incredible first psychedelic experience? An experienced psychonaut with decades of use? Or just an interested bystander, curious about the relevance of psychedelics to health and wellness? Regardless of your why, our podcast gives you a unique look into how psychedelic substances change culture and society for the better.
RSS Feed Subscribe in Apple Podcasts
The Third Wave
2021
October
September
August
June
May
April
March
February
January


2020
December
November
October
September
August
July
June
May
April
March
February
January


2019
December
November
October
January


2018
December
November
October
September
August
July
June
May
April
March
February
January


2017
August
July
June
May
April
March
February
January


All Episodes
Archives
Now displaying: Page 1
May 2, 2021

After a successful career in entrepreneurship and cryptocurrency, Ryan Zurrer turned his attention to the burgeoning psychedelic space. As he continued to learn more via research, attending conferences, and speaking with others, he became concerned about what he considers the “dystopian future” of psychedelic therapies - sterile doctors’ offices, $8000 treatments, synthetic drugs, no community or connection. Determined to help others harness the powerful benefits of plant medicines in traditional settings, he started Vine Ventures, a VC fund focusing on a future in which everyone who wants to access a psychedelic experience can do so safely, legally, and affordably. In this episode, Ryan and Paul discuss the importance of accessibility, Ryan’s criteria for investment, and the differences between a centralized and decentralized approach to therapy and legalization.

0 Comments
Adding comments is not available at this time.